12/04/2014
Four Vanderbilt University technologies earned U.S. patent protection in November. They include methods, catalysts, and intermediates for the synthesis of specific compounds, monoclonal antibodies for H1N1, and a novel apparatus and methods for percutaneous cochlear implants.
|
Monoclonal antibodies to influenza H1N1 virus uses thereof |
|
|
Stereoselective methods, catalysts and intermediates for the synthesis of (-)-Nutlin-3 and related compounds |
|
|
Apparatus and methods for percutaneous cochlear implantation |